Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
ImmunityBio (IBRX) Stock Falls Following FDA Warning Letter Response - News and Statistics
ImmunityBio’s (IBRX) stock declined after the company responded to a U.S. Food and Drug Administration (FDA) warning letter regarding promotional materials for its cancer drug Anktiva. The FDA identified a television advertisement and a podcast episode as false or misleading. ImmunityBio stated the ad was never aired publicly and that it removed the podcast and sought its removal from other platforms, actions that contributed to a slight dip in investor sentiment.